rs104894820
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 9P and 4B. PM1PM5PP2PP3_StrongBS2
The NM_000166.6(GJB1):c.37G>A(p.Val13Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,208,459 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V13L) has been classified as Pathogenic.
Frequency
Consequence
NM_000166.6 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease X-linked dominant 1Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)
- X-linked progressive cerebellar ataxiaInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000166.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GJB1 | NM_000166.6 | MANE Select | c.37G>A | p.Val13Met | missense | Exon 2 of 2 | NP_000157.1 | ||
| GJB1 | NM_001097642.3 | c.37G>A | p.Val13Met | missense | Exon 2 of 2 | NP_001091111.1 | |||
| GJB1 | NM_001440770.1 | c.37G>A | p.Val13Met | missense | Exon 3 of 3 | NP_001427699.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GJB1 | ENST00000361726.7 | TSL:1 MANE Select | c.37G>A | p.Val13Met | missense | Exon 2 of 2 | ENSP00000354900.6 | ||
| GJB1 | ENST00000374029.2 | TSL:5 | c.37G>A | p.Val13Met | missense | Exon 2 of 2 | ENSP00000363141.1 | ||
| GJB1 | ENST00000447581.2 | TSL:5 | c.37G>A | p.Val13Met | missense | Exon 3 of 3 | ENSP00000407223.2 |
Frequencies
GnomAD3 genomes AF: 0.0000538 AC: 6AN: 111534Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000602 AC: 11AN: 182766 AF XY: 0.0000297 show subpopulations
GnomAD4 exome AF: 0.0000164 AC: 18AN: 1096925Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 5AN XY: 362319 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000538 AC: 6AN: 111534Hom.: 0 Cov.: 23 AF XY: 0.0000593 AC XY: 2AN XY: 33740 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:2
The c.37G>A;p.(Val13Met) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 637129; PMID: 22944031) - PS4_moderate. The variant is located in a mutational hot spot and/or critical and well-established functional domain (Connexin) - PM1. The variant is present at low allele frequencies population databases (rs104894820 - gnomAD 0.0006019%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. Pathogenic missense variant in this residue have been reported (ClinVar ID: 10439 - c.37G>T;p.(Val13Leu); PMID: 27544631 - p.(Val13Glu)) - PM5. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is likely pathogenic.
Charcot-Marie-Tooth disease Uncertain:1
Inborn genetic diseases Uncertain:1
The p.V13M variant (also known as c.37G>A), located in coding exon 1 of the GJB1 gene, results from a G to A substitution at nucleotide position 37. The valine at codon 13 is replaced by methionine, an amino acid with highly similar properties. This alteration has been detected in a small number of individuals who are described as carrying a diagnosis of Charcot-Marie-Tooth neuropathy (Bone LJ et al. Neurobiol Dis, 1997;4:221-30; Liu L et al. Clin Genet, 2017 Jun;91:881-891; Panosyan FB et al. Neurology, 2017 Aug;89:927-935). Based on data from gnomAD, the A allele has an overall frequency of 0.006% (11/182,766) total alleles studied, with 2 hemizygotes observed. The highest observed frequency was 0.033% (9/27,415) of Latino alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Charcot-Marie-Tooth Neuropathy X Benign:1
not provided Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at